| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.31 | 4e-07 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.24 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |